Daiwa Securities Group’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5K | Hold |
70
| – | – | ﹤0.01% | 1155 |
|
|
2025
Q1 | $5K | Hold |
70
| – | – | ﹤0.01% | 1126 |
|
|
2024
Q4 | $4K | Hold |
70
| – | – | ﹤0.01% | 1169 |
|
|
2024
Q3 | $4K | Hold |
70
| – | – | ﹤0.01% | 1174 |
|
|
2024
Q2 | $4K | Hold |
70
| – | – | ﹤0.01% | 1197 |
|
|
2024
Q1 | $5K | Hold |
70
| – | – | ﹤0.01% | 1196 |
|
|
2023
Q4 | $4K | Hold |
70
| – | – | ﹤0.01% | 1208 |
|
|
2023
Q3 | $4K | Hold |
70
| – | – | ﹤0.01% | 1163 |
|
|
2023
Q2 | $4K | Hold |
70
| – | – | ﹤0.01% | 1183 |
|
|
2023
Q1 | $3K | Hold |
70
| – | – | ﹤0.01% | 1166 |
|
|
2022
Q4 | $3K | Buy |
+70
| New | +$3K | ﹤0.01% | 1179 |
|
|
2021
Q4 | – | Sell |
-27
| Closed | -$1K | – | 1378 |
|
|
2021
Q3 | $1K | Hold |
27
| – | – | ﹤0.01% | 1254 |
|
|
2021
Q2 | $1K | Hold |
27
| – | – | ﹤0.01% | 1173 |
|
|
2021
Q1 | $1K | Hold |
27
| – | – | ﹤0.01% | 1183 |
|
|
2020
Q4 | $1K | Sell |
27
-41
| -60% | -$1.52K | ﹤0.01% | 1159 |
|
|
2020
Q3 | $2K | Hold |
68
| – | – | ﹤0.01% | 1126 |
|
|
2020
Q2 | $3K | Hold |
68
| – | – | ﹤0.01% | 1117 |
|
|
2020
Q1 | $3K | Hold |
68
| – | – | ﹤0.01% | 1119 |
|
|
2019
Q4 | $4K | Sell |
68
-8
| -11% | -$471 | ﹤0.01% | 1108 |
|
|
2019
Q3 | $6K | Hold |
76
| – | – | ﹤0.01% | 1051 |
|
|
2019
Q2 | $6K | Buy |
76
+12
| +19% | +$947 | ﹤0.01% | 1064 |
|
|
2019
Q1 | $5K | Hold |
64
| – | – | ﹤0.01% | 1066 |
|
|
2018
Q4 | $3K | Hold |
64
| – | – | ﹤0.01% | 1072 |
|
|
2018
Q3 | $4K | Hold |
64
| – | – | ﹤0.01% | 1073 |
|
|
2018
Q2 | $4K | Hold |
64
| – | – | ﹤0.01% | 1092 |
|
|
2018
Q1 | $4K | Buy |
+64
| New | +$4K | ﹤0.01% | 1076 |
|